2023 was a troublesome calendar year for that biopharma field, with various providers downsizing and restructuring their workforces to remain afloat. You'll find indications of Restoration, as mergers and acquisitions picked up throughout the pharmaceutical and lifestyle sciences sector inside the latter Element of 2023 and have ongoing their upswing https://sites.google.com/view/bio-sites/blog